These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 25951104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
    Miller RA, Waters LL, Mody DR, Tams KC.
    Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H, Mody RR, Luna E, Armylagos D, Xu J, Schwartz MR, Mody DR, Ge Y.
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z, Austin RM, Guo M, Zhao C.
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [Abstract] [Full Text] [Related]

  • 8. Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
    Goetz LH, Evans HL, Armylagos D, Zhou H, Mody DR, Schwartz MR, Ge Y.
    J Am Soc Cytopathol; 2024 Dec; 13(3):227-232. PubMed ID: 38401997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Walker JL, Darcy KM, Carter R, Hatae M, Levine L, Spirtos NM, Stanbridge EJ.
    Int J Cancer; 2009 Nov 15; 125(10):2434-40. PubMed ID: 19670419
    [Abstract] [Full Text] [Related]

  • 12. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
    Ge Y, Christensen PA, Luna E, Armylagos D, Xu J, Hsu JW, Zhou H, Schwartz MR, Mody DR.
    Cancer Cytopathol; 2019 Dec 15; 127(12):757-764. PubMed ID: 31589379
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S, Negri G, Sideri M, Santini D, Martinelli G, Venturoli S, Pelusi C, Syrjanen S, Syrjanen K, Pelusi G.
    Gynecol Oncol; 2007 Jul 15; 106(1):170-6. PubMed ID: 17481701
    [Abstract] [Full Text] [Related]

  • 14. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP, Li RZ, Wu LN, Li J, Liu ZH, Wang C, Zhou YQ, Weng LM, Wu RF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun 15; 30(6):626-30. PubMed ID: 19957634
    [Abstract] [Full Text] [Related]

  • 15. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N, Othman NH.
    Asian Pac J Cancer Prev; 2014 Jun 15; 15(5):2245-9. PubMed ID: 24716964
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T.
    Cancer; 2004 Apr 25; 102(2):100-8. PubMed ID: 15098254
    [Abstract] [Full Text] [Related]

  • 17. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
    Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS.
    Cancer Cytopathol; 2015 May 25; 123(5):282-8. PubMed ID: 25864682
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL, CCCaST Study Group.
    Int J Cancer; 2006 Aug 01; 119(3):615-23. PubMed ID: 16572425
    [Abstract] [Full Text] [Related]

  • 19. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
    Zhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, Zhou Z, Si Q, Fischer AH, Sturgis CD, Jing X, Marshall CB, Witt BL, Birdsong GG, Crothers BA.
    Arch Pathol Lab Med; 2015 Feb 01; 139(2):184-8. PubMed ID: 24694342
    [Abstract] [Full Text] [Related]

  • 20. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
    Kanber Y, Charbonneau M, Auger M.
    Cancer Cytopathol; 2015 Dec 01; 123(12):739-44. PubMed ID: 26348845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.